WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-47 Cr | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-47 Cr |
| Mar2025 | ₹-463 Cr |
| Mar2024 | ₹-559 Cr |
| Mar2023 | ₹-244 Cr |
| Mar2022 | ₹686 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-47 Cr | Negative | |
| Mar2025 | ₹-463 Cr | Negative | |
| Mar2024 | ₹-559 Cr | Negative | |
| Mar2023 | ₹-244 Cr | Negative | |
| Mar2022 | ₹686 Cr | - | |
Compare Consolidated Net Profit of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹29,659.5 Cr | -4.7% | -3.6% | 22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -4.7% |
-3.6% |
22.7% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses